Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalised Medicine in the Early Identification of Preclinical Cognitive Impairment. Development of a Predictive Risk Model.

NCT06114290 is registered in ClinicalTrials.gov with Instituto de Salud Carlos III as lead sponsor.

NCT NCT06114290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06114290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalised Medicine in the Early Identification of Preclinical Cognitive Impairment. Development of a Predictive Risk Model.
Lead sponsor
Instituto de Salud Carlos III
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2023
Completion date
July 31, 2025
Enrollment
1,150 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction